Matt Vassar

Matt Vassar

Oklahoma State University

H-index: 34

North America-United States

About Matt Vassar

Matt Vassar, With an exceptional h-index of 34 and a recent h-index of 31 (since 2020), a distinguished researcher at Oklahoma State University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Exploring Data Sharing Practices in Ophthalmology Journals: A Cross-sectional Analysis

Gender disparities in neuropsychological assessment research in drug abuse populations: A systematic review

Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis

Understanding Public Perception of Naloxone: A Study of FAQs and Answer Source Credibility

The Current State of Health Inequities in COPD

Assessing patient burden and benefit: A decade of cabozantinib clinical trials

A scoping review of health inequities in alcohol use disorder

Delayed discovery: the COVID-19 pandemic’s influence on osteoarthritis clinical trials

Matt Vassar Information

University

Position

___

Citations(all)

5690

Citations(since 2020)

4418

Cited By

2798

hIndex(all)

34

hIndex(since 2020)

31

i10Index(all)

120

i10Index(since 2020)

111

Email

University Profile Page

Google Scholar

Top articles of Matt Vassar

Exploring Data Sharing Practices in Ophthalmology Journals: A Cross-sectional Analysis

2024/2/16

Matt Vassar
Matt Vassar

H-Index: 23

Gender disparities in neuropsychological assessment research in drug abuse populations: A systematic review

2024/2/6

Matt Vassar
Matt Vassar

H-Index: 23

Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis

Thrombosis Research

2024/2/1

Matt Vassar
Matt Vassar

H-Index: 23

Understanding Public Perception of Naloxone: A Study of FAQs and Answer Source Credibility

Substance Use & Misuse

2024/4/16

Matt Vassar
Matt Vassar

H-Index: 23

The Current State of Health Inequities in COPD

2024/2/1

Matt Vassar
Matt Vassar

H-Index: 23

Assessing patient burden and benefit: A decade of cabozantinib clinical trials

International Journal of Cancer

2024/4/15

A scoping review of health inequities in alcohol use disorder

2024/2/1

Matt Vassar
Matt Vassar

H-Index: 23

Delayed discovery: the COVID-19 pandemic’s influence on osteoarthritis clinical trials

Journal of Osteopathic Medicine

2024/1/4

Matt Vassar
Matt Vassar

H-Index: 23

Reporting of Complications in Rhinoplasty Randomized Controlled Trials: An Analysis Using the CONSORT Extension for Harms Checklist

Otolaryngology–Head and Neck Surgery

2024/4/12

Andrew Wilson
Andrew Wilson

H-Index: 6

Matt Vassar
Matt Vassar

H-Index: 23

Assessing the uptake of the type 1 diabetes core outcome set in randomized controlled trials: A Cross-Sectional study

Diabetes Research and Clinical Practice

2024/1/1

Matt Vassar
Matt Vassar

H-Index: 23

Evaluating Guideline and Registration Policies Among Neurology Journals: A Cross-Sectional Analysis.

2024/4/1

Matt Vassar
Matt Vassar

H-Index: 23

Reporting of Harms in Randomized Controlled Trials Published in Urology Journals: An Updated Analysis

2014/5/1

Assessment of Rehabilitation Journal Requirements for the Use of Reporting Guidelines and Clinical Trial Registration

Archives of Physical Medicine and Rehabilitation

2024/3/30

Caleb Smith
Caleb Smith

H-Index: 1

Matt Vassar
Matt Vassar

H-Index: 23

Data-sharing across otolaryngology: comparing journal policies and their adherence to the FAIR principles

Annals of Otology, Rhinology & Laryngology

2024/1

Adam Schultz
Adam Schultz

H-Index: 16

Matt Vassar
Matt Vassar

H-Index: 23

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Lenvatinib Clinical Trials: A Systematic Review

2023/7/21

SUBOPTIMAL REPORTING OF ADVERSE EVENTS IN RCTs SUPPORTING BLADDER CANCER CLINICAL PRACTICE GUIDELINES

Urologic Oncology: Seminars and Original Investigations

2024/3/1

Matt Vassar
Matt Vassar

H-Index: 23

Inadequate harms reporting among randomized controlled trials cited as supporting evidence in the AAOS management of hip fractures in older adults clinical practice guideline …

Injury

2024/3/1

Matt Vassar
Matt Vassar

H-Index: 23

Assessing the Degree to which Randomized Control Trials Align with the Core Outcome Set for Osteoarthritis of Knee and Hip: A Cross-Sectional Analysis

Osteoarthritis and Cartilage

2024/2/23

Matt Vassar
Matt Vassar

H-Index: 23

Exploring Affordable Solutions for Orthopedic Medications: A Comparative Study of Mark Cuban Cost Plus Drug Company (MCCPDC) and Medicare

2024/2/16

Influence of Publications on the Management of Appendicitis

2024/2/16

See List of Professors in Matt Vassar University(Oklahoma State University)